Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
Conditions: Breast Cancer; Endocrine Therapy; CDK4/6 Inhibitors; Subsequent Treatment Intervention: Drug: Different treatment regimens following progression on CDK4/6 inhibitors. Sponsor: Hunan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials